CD24 and cancer: Basal B cell lines, like MDA-MB-231 or SUM159PT have a mesenchymal-like phenotype and features of cancer stem cells (CD44+ CD24−/low, ALDH1+) [60], indicating that Cyr61 is associated with a more aggressive phenotype.